Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina

Thrombosis Research

Volumn 128, Issue 6, 2011, Pages 547-551

  Kajiwara, Ichiro ^a   Soejima, Hirofumi ^a,b   Miyamoto, Shinzo ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Angina; Aspirin; Coronary artery disease; Plasminogen activator inhibitor; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR; SARPOGRELATE; SEROTONIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; STABLE ANGINA PECTORIS; THORAX PAIN; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

ADULT; AGED; ANGINA, STABLE; ASPIRIN; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN INACTIVATORS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SEROTONIN; SUCCINATES;

EID: 82355173434     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.06.001     Document Type: Article

References (33)

1. M. Pignone, M.J. Alberts, J.A. Colwell, M. Cushman, S.E. Inzucchi, D. Mukherjee, R.S. Rosenson, C.D. Williams, P.W. Wilson, and M.S. Kirkman Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation Circulation 121 2010 2694 2701
2. Antithrombotic Trialists' (ATT) Collaboration C. Baigent, L. Blackwell, R. Collins, J. Emberson, J. Godwin, R. Peto, J. Buring, C. Hennekens, P. Kearney, T. Meade, C. Patrono, M.C. Roncaglioni, and A. Zanchetti Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
3. Y. Ozaki, K. Satoh, Y. Yatomi, T. Yamamoto, Y. Shirasawa, and S. Kume Detection of plateletaggregates with a particle counting method using light scattering Anal Biochem 218 1994 284 294 (Pubitemid 24141625)
4. K. Satoh, Y. Ozaki, R. Qi, L. Yang, N. Asazuma, Y. Yatomi, and S. Kume Factors that affect the size of platelet aggregates in epinephrine-induced activation: A study using the particle counting method based on light scattering Thromb Res 81 1996 515 523 (Pubitemid 26101333)
5. K. Eto, S. Takeshita, M. Ochiai, Y. Ozaki, T. Sato, and T. Isshiki Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser scattering to assess platelet aggregability Cardiovasc Res 40 1998 223 229 (Pubitemid 28435447)
6. S. Miyamoto, H. Ogawa, H. Soejima, K. Takazoe, I. Kajiwara, T. Sakamoto, M. Yoshimura, K. Kugiyama, and H. Yasue Increased rate of formation of small-sized platelet aggregates in patients with acute coronary syndromes Jpn Circ J 64 2000 647 652
7. R. Shirakawa, T. Higashi, A. Tabuchi, A. Yoshioka, H. Nishioka, M. Fukuda, T. Kita, and H. Horiuchi Munc13-4 is a GTP-Rab27-binding protein regulating dense core granule secretion in platelets J Biol Chem 279 2004 10730 10737 (Pubitemid 38372686)
8. S.T. Crowley, E.C. Dempsey, K.B. Horwitz, and L.D. Horwitz Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate Circulation 90 1994 1908 1918 (Pubitemid 24320942)
9. V.K. Puri, M. Verma, A.K. Saxena, and K. Shanker Platelet serotonergic mechanisms in ischemic heart disease Thromb Res 57 1990 445 451 (Pubitemid 20096654)
10. R. Qi, Y. Ozaki, K. Satoh, K. Kurota, N. Asazuma, Y. Yatomi, and S. Kume Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotonin Thromb Res 81 1996 43 54 (Pubitemid 26027722)
11. H. Kawano, H. Tsuji, H. Nishimura, S. Kimura, S. Yano, N. Ukimura, Y. Kunieda, M. Yoshizumi, T. Sugano, K. Nakagawa, H. Masuda, S. Sawada, and M. Nakagawa Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells Blood 97 2001 1697 1702 (Pubitemid 32217236)
12. G.H. Tofler, D. Brezinski, A.I. Schafer, C.A. Czeisler, J.D. Rutherford, S.N. Willich, R.E. Gleason, G.H. Williams, and J.E. Muller Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death N Engl J Med 316 1987 1514 1518 (Pubitemid 17076236)
13. M.H. Pietraszek, T. Urano, K. Serizawa, S. Takahashi, K. Sumiyoshi, Y. Takada, and A. Takada Circadian rhythm of serotonin: influence of age Thromb Res 60 1990 253 257
14. H. Ogawa, H. Yasue, S. Oshima, K. Okumura, K. Matsuyama, and K. Obata Circadian variation of plasma fibrinopeptide A level in patients with variant angina Circulation 80 1989 1617 1626 (Pubitemid 20031691)
15. M. Picard, D. Olichon, and J. Gombert Determination of serotonin in plasma by liquid chromatography with electrochemical detection J Chromatogr 341 1985 445 451 (Pubitemid 15013692)
16. T. Yamamoto, Y. Egawa, Y. Shirasawa, Y. Ozaki, Y. Yatomi, and S. Kume a laser light Scattering in situ system for counting aggregates in blood platelet aggregation Meas Sci Technol 6 1995 174 180
17. I. Kajiwara, H. Ogawa, H. Soejima, K. Takazoe, S. Miyamoto, T. Sakamoto, M. Yoshimura, K. Kugiyama, and H. Yasue The prognostic value of small-sized platelet aggregates in unstable angina: detection by a novel laser-light scattering method Thromb Res 101 2001 109 118 (Pubitemid 32176016)
18. S. Miyamoto, H. Kawano, T. Sakamoto, H. Soejima, I. Kajiwara, H. Shimomura, S. Kojima, J. Hokamaki, S. Sugiyama, N. Hirai, M. Yoshimura, Y. Ozaki, and H. Ogawa Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease Thromb Haemost 89 2003 681 686 (Pubitemid 36456965)
19. S. Miyamoto, H. Kawano, T. Kudoh, H. Soejima, S. Kojima, J. Hokamaki, H. Maruyoshi, T. Sakamoto, M. Yoshimura, Y. Ozaki, and H. Ogawa Usefulness of preprocedural platelet aggregation to predict restenosis after percutaneous coronary intervention Am J Cardiol 96 2005 71 73 (Pubitemid 40853944)
20. T. Kudoh, T. Sakamoto, S. Miyamoto, K. Matsui, S. Kojima, S. Sugiyama, M. Yoshimura, Y. Ozaki, and H. Ogawa Relation between platelet microaggregates and ankle brachial index in patients with peripheral arterial disease Thromb Res 117 2006 263 269 (Pubitemid 41832297)
21. E. Eriksson, M. Ranby, E. Guyzander, and B. Risberg Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-d-lysine stimulated assay Thromb Res 50 1988 91 101
22. T. Sakamoto, H. Ogawa, K. Takazoe, M. Yoshimura, H. Shimomura, Y. Moriyama, H. Arai, and K. Okajima Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase: comparison with unfractionated heparin J Am Coll Cardiol 42 2003 1389 1394 (Pubitemid 37267278)
23. Y. Miyao, K. Fujimoto, K. Kugiyama, H. Kawano, N. Hirai, S. Sugiyama, T. Sakamoto, M. Yoshimura, and H. Ogawa Plasminogen activator inhibitor contributes to the coronary wall thickening in patients with angiographically normal coronary Thromb Res 112 2003 123 129 (Pubitemid 38201598)
24. G.M. Nemecek, S.R. Coughlin, D.A. Handley, and M.A. Moskowitz Stimulation of aortic smooth muscle cell mitogenesis by serotonin Proc Natl Acad Sci U S A 83 1986 674 678 (Pubitemid 16035536)
25. S.L. Lee, W.W. Wang, B.J. Moore, and B.L. Fanburg Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture Circ Res 68 1991 1362 1368
26. T. Ito, U. Ikeda, M. Shimpo, K. Yamamoto, and K. Shimada Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells Circulation 102 2000 2522 2527
27. F.F.P.D. Clerck Serotonin and amplification mechanisms in platelet reactions NIPS 4 1989 130 133
28. T. Sakamoto, H. Ogawa, H. Kawano, N. Hirai, S. Miyamoto, K. Takazoe, H. Soejima, K. Kugiyama, M. Yoshimura, and H. Yasue Rapid change of platelet aggregability in acute hyperglycemia. Detection by a novel laser-light scattering method Thromb Haemost 83 2000 475 479 (Pubitemid 30148364)
29. K. Vikenes, M. Farstad, and J.E. Nordrehaug Serotonin is associated with coronary artery disease and cardiac events Circulation 100 1999 483 489 (Pubitemid 29360156)
30. K. Takazoe, H. Ogawa, H. Yasue, T. Sakamoto, H. Soejima, Y. Miyao, H. Kawano, Y. Moriyama, K. Misumi, H. Suefuji, K. Kugiyama, and M. Yoshimura Increased plasminogen activator inhibitor activity and diabetes predict subsequent coronary events in patients with angina pectoris Ann Med 33 2001 206 212 (Pubitemid 32417625)
31. A. Smith, C. Patterson, J. Yarnell, A. Rumley, Y. Ben-Shlomo, and G. Lowe Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study Circulation 112 2005 3080 3087 (Pubitemid 43113439)
32. H. Soejima, H. Ogawa, H. Yasue, K. Kaikita, K. Nishiyama, K. Misumi, K. Takazoe, Y. Miyao, M. Yoshimura, K. Kugiyama, S. Nakamura, I. Tsuji, and K. Kumeda Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina Circulation 99 1999 2908 2913 (Pubitemid 29258979)
33. P.E. Morange, S. Blankenberg, M.C. Alessi, C. Bickel, H.J. Rupprecht, R. Schnabel, E. Lubos, T. Münzel, D. Peetz, V. Nicaud, I. Juhan-Vague, L. Tiret Atherogene Investigators Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study J Thromb Haemost 5 2007 475 482 (Pubitemid 46680678)